Person:
García Gámiz, Mercedes

Loading...
Profile Picture
First Name
Mercedes
Last Name
García Gámiz
Affiliation
Universidad Complutense de Madrid
Faculty / Institute
Farmacia
Department
Microbiología y Parasitología
Area
Microbiología
Identifiers
UCM identifierScopus Author IDDialnet ID

Search Results

Now showing 1 - 2 of 2
  • Item
    Protocolo de Hemorragia Obstétrica Severa. Hospital Universitario Gregorio Marañón
    (2016) Morillas Ramírez, Francisco; Pérez Lucas, Raquel; Anguita Velasco, Carlos Javier; Perez Corral, Ana; Palacio Abizanda, Francisco; Cuesta Campins, Nieves; García Ruiz, Esther María; Ruiz Labarta, Javier; Rodriguez Rosales, Gracia; García Gámiz, Mercedes; León Luis, Juan Antonio; Pintado Recarte, María Del Pilar; Bermejo Albares, Lourdes; Pascual Izquierdo, María Cristina; Maricalva Agudo, Barbara; Martínez Fernández-Llamazares, Cecilia
    Protocolo de Hemorragia Obstétrica Severa que tiene por objetivos: - Integrar y coordinar al personal y servicios hospitalarios implicados en el cuidado de la paciente obstétrica y definir sus responsabilidades durante la activación y desarrollo del Protocolo. - Estandarizar de forma eficiente y eficaz el envío de hemoderivados. - Disponer de la información necesaria para prevenir y tratar en nuestro medio a las pacientes que presentan una HOS, según la evidencia disponible y con la finalidad de evitar la variabilidad de criterios. - Control del riesgo de sucesos clínicos adversos con el fin de evitar el manejo subóptimo de la situación. - Registrar de forma eficaz todos los datos generados durante el suceso, con la finalidad de valorar periódicamente la evolución del problema.
  • Item
    Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia
    (PLoS One, 2015) Gordo Remartínez , Susana; Calderón Moreno, María; Fernández Herranz, Juan; Castuera Gil, Ana; Gallego Alonso-Colmenares, María Del Mar; Puertas López, Carolina; Nuevo González, José Antonio; Sánchez Sendín, Domingo; García Gámiz, Mercedes; Sevillano Fernández, José Antonio; Álvarez Sala, Luis A.; Andueza Lillo, Juan Antonio; Salas Álvarez, Jesús De La Ascensión; Miguel Yanes, José María De
    Background midregional proadrenomedullin (MR-proADM) is a prognostic biomarker in patients with community-acquired pneumonia (CAP). We sought to confirm whether MR-proADM added to Pneumonia Severity Index (PSI) improves the potential prognostic value of PSI alone, and tested to what extent this combination could be useful in predicting poor outcome of patients with CAP in an Emergency Department (ED). Methods Consecutive patients diagnosed with CAP were enrolled in this prospective, single-centre, observational study. We analyzed the ability of MR-proADM added to PSI to predict poor outcome using receiver operating characteristic (ROC) curves, logistic regression and risk reclassification and comparing it with the ability of PSI alone. The primary outcome was “poor outcome”, defined as the incidence of an adverse event (ICU admission, hospital readmission, or mortality at 30 days after CAP diagnosis). Results 226 patients were included; 33 patients (14.6%) reached primary outcome. To predict primary outcome the highest area under curve (AUC) was found for PSI (0.74 [0.64-0.85]), which was not significantly higher than for MR-proADM (AUC 0.72 [0.63-0.81, p > 0.05]). The combination of PSI and MR-proADM failed to improve the predictive potential of PSI alone (AUC 0.75 [0.65-0.85, p=0.56]). Ten patients were appropriately reclassified when the combined PSI and MR-proADM model was used as compared with the model of PSI alone. Net reclassification improvement (NRI) index was statistically significant (7.69%, p = 0.03) with an improvement percentage of 3.03% (p = 0.32) for adverse event, and 4.66% (P = 0.02) for no adverse event. Conclusion MR-proADM in combination with PSI may be helpful in individual risk stratification for short-term poor outcome of CAP patients, allowing a better reclassification of patients compared with PSI alone.